Which diuretic can be used in renal failure?
Which of the following side effects is associated with Spironolactone?
A 64-year-old man with heart failure is recently started on 80 mg/day of furosemide. He now feels weak and tired, but notes that his heart failure symptoms have improved. There is no change in his urine output and he gets a good diuretic response every time he takes his furosemide. Which are the characteristic ECG findings?
Which of the following drugs prevents renal stones?
What is the mechanism of action of furosemide in left ventricular failure (LVF)?
A patient arrives in the emergency room in a coma and has a serum Ca 2+ of 4.5 mM. You start a saline infusion of which of the following drugs?
Which of the following thiazide diuretics remains active when the Glomerular Filtration Rate (GFR) is 30-40 mL/min?
Which of the following diuretics causes impaired glucose tolerance?
Which of the following diuretics is used in the given condition?

Which diuretic is used in the management of mountain sickness?
Explanation: **Explanation:** **Furosemide** is the correct answer because it is a high-ceiling loop diuretic that remains effective even when the Glomerular Filtration Rate (GFR) falls below 30 mL/min. In renal failure, the delivery of solutes to the distal nephron is reduced; loop diuretics are potent enough to inhibit the $Na^+-K^+-2Cl^-$ symporter in the thick ascending limb, maintaining diuresis and managing fluid overload in patients with chronic kidney disease (CKD). **Why the other options are incorrect:** * **Chlorothiazide & Chlorthalidone:** These are Thiazide/Thiazide-like diuretics. They generally lose their efficacy when GFR is less than 30 mL/min (except for Metolazone and Indapamide). Using them in advanced renal failure is ineffective for fluid management. * **Mannitol:** This is an osmotic diuretic. In renal failure, Mannitol is not excreted efficiently, leading to its accumulation in the extracellular fluid. This causes "osmotic shift," drawing water out of cells and potentially leading to acute pulmonary edema or congestive heart failure. It is contraindicated in established anuria. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Furosemide is the drug of choice for acute pulmonary edema and edema associated with CKD. * **Metolazone Exception:** While most thiazides fail in renal failure, Metolazone can be combined with Loop diuretics (Sequential Nephron Blockade) to treat refractory edema in CKD patients. * **Ototoxicity:** Furosemide can cause dose-dependent ototoxicity, especially when administered rapidly IV or combined with aminoglycosides. * **Electrolyte Profile:** Loop diuretics cause "Hypo-everything" (Hypokalemia, Hypomagnesemia, Hypocalcemia), except for Hyperuricemia and Hyperglycemia.
Explanation: **Explanation:** **Spironolactone** is a potassium-sparing diuretic that acts as a competitive antagonist of the **Mineralocorticoid Receptor (Aldosterone receptor)** in the late distal tubule and collecting duct. **Why Hyperkalemia is Correct:** Aldosterone normally promotes the reabsorption of sodium ($Na^+$) and the excretion of potassium ($K^+$) and hydrogen ions ($H^+$). By blocking this receptor, Spironolactone prevents $K^+$ secretion into the tubular lumen. This leads to the retention of potassium in the blood, resulting in **Hyperkalemia**, its most significant and potentially life-threatening side effect. **Analysis of Incorrect Options:** * **A. Alkalosis:** Spironolactone causes **Metabolic Acidosis** (not alkalosis) because it inhibits the excretion of $H^+$ ions. * **B. Hirsutism:** Spironolactone actually has **anti-androgenic** properties (it blocks androgen receptors and inhibits steroidogenesis). Therefore, it is used to *treat* hirsutism in conditions like PCOS. A common side effect in males, however, is **gynecomastia**. * **D. Hyperglycemia:** This is a classic side effect of **Thiazides and Loop diuretics**, which can impair insulin release. Spironolactone does not typically affect blood glucose levels. **High-Yield Clinical Pearls for NEET-PG:** * **Eplerenone** is a more selective aldosterone antagonist with fewer endocrine side effects (less risk of gynecomastia) compared to Spironolactone. * **Drug Interaction:** Avoid combining Spironolactone with ACE inhibitors or ARBs, as this significantly increases the risk of severe hyperkalemia. * **Indication of Choice:** It is the diuretic of choice for patients with **Cirrhosis with Ascites** and is proven to reduce mortality in **Chronic Heart Failure (NYHA Class II-IV)**.
Explanation: ### Explanation **Correct Answer: C. Lengthened QU interval** **1. Underlying Medical Concept:** Furosemide is a potent loop diuretic that inhibits the Na⁺/K⁺/2Cl⁻ symporter in the thick ascending limb of the Loop of Henle. A common and significant side effect of loop diuretics is **hypokalemia** (low serum potassium). In hypokalemia, the ECG undergoes characteristic changes due to delayed ventricular repolarization. The most classic finding is the appearance of **prominent U waves**. As the U wave becomes more pronounced and the T wave flattens, the T and U waves often merge. This creates the appearance of a **"lengthened QU interval"** (or a pseudo-prolonged QT interval), which is a hallmark of potassium depletion. The patient’s symptoms of weakness and fatigue are clinical indicators of this electrolyte imbalance. **2. Why the other options are incorrect:** * **A & B (PR Interval):** Changes in the PR interval are typically associated with calcium abnormalities or AV nodal blocks (e.g., Digoxin toxicity), not primarily with the hypokalemia caused by diuretics. * **D (Shortened QT interval):** A shortened QT interval is characteristic of **hypercalcemia**. In contrast, hypokalemia (and hypocalcemia) typically leads to a prolonged appearance of the repolarization phase (prolonged QU/QT). **3. NEET-PG High-Yield Pearls:** * **ECG findings in Hypokalemia:** Flattening/inversion of T waves, ST-segment depression, prominent U waves, and QU prolongation. * **Loop Diuretics Side Effects (Mnemonic: OH DANG!):** **O**totoxicity, **H**ypokalemia, **D**ehydration, **A**llergy (sulfa), **N**ephritis (interstitial), **G**out (hyperuricemia). * **Metabolic state:** Loop diuretics cause **Hypokalemic Metabolic Alkalosis**. * **U wave:** A positive deflection after the T wave, representing slow repolarization of Purkinje fibers. It is most visible in precordial leads V2–V4.
Explanation: The correct answer is **Acetazolamide**. This question focuses on the specific management of **Cystinuria** and the prevention of **Cystine stones**. **1. Why Acetazolamide is correct:** Acetazolamide is a Carbonic Anhydrase inhibitor that acts on the proximal convoluted tubule [1, 2]. By inhibiting the reabsorption of bicarbonate, it increases urinary bicarbonate excretion, leading to **alkalinization of the urine** [1, 2]. Cystine is highly insoluble in acidic urine but becomes significantly more soluble as the pH rises above 7.5. Therefore, by making the urine alkaline, Acetazolamide prevents the precipitation of cystine crystals and the formation of renal stones in patients with cystinuria [1]. **2. Why the other options are incorrect:** * **Hydrochlorothiazide:** While Thiazides are used to prevent **Calcium Oxalate** stones (by increasing distal tubular calcium reabsorption and reducing hypercalciuria) [3], they do not prevent cystine stones. * **Mannitol:** This is an osmotic diuretic used primarily to reduce intracranial or intraocular pressure. It has no specific role in stone prevention. * **Furosemide:** This loop diuretic **increases** urinary calcium excretion (hypercalciuria) [3]. Consequently, it can actually promote the formation of calcium-containing renal stones. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice for Hypercalciuria stones:** Thiazides (e.g., Chlorthalidone, Hydrochlorothiazide) [3]. * **Drug that causes stones:** Acetazolamide can paradoxically cause **Calcium Phosphate** stones because alkaline urine promotes calcium phosphate precipitation, even though it prevents cystine stones [1, 2]. * **Loop Diuretics (Furosemide):** "Loops lose Calcium" (used in treating hypercalcemia) [3]. * **Thiazides:** "Thiazides take Calcium" (reabsorb it back into the blood; used in treating hypercalciuria) [3].
Explanation: **Mechanism of Action:** Furosemide is a potent **Loop Diuretic**. Its primary mechanism involves the inhibition of the **Naⁱ-Kⁱ-2Clⁱ symporter (NKCC2)** [1] located in the luminal membrane of the **Thick Ascending Limb (TAL)** of the Henle’s loop [2]. By blocking this transporter, it prevents the reabsorption of these electrolytes, leading to profound diuresis and natriuresis [3]. **Role in Left Ventricular Failure (LVF):** In acute LVF (Pulmonary Edema), furosemide acts via two distinct phases [4]: 1. **Immediate Effect (Vascular):** It causes rapid **venodilation** (mediated by prostaglandins), which increases venous capacitance and decreases preload. This provides symptomatic relief even before the onset of diuresis. 2. **Delayed Effect (Renal):** It reduces fluid overload through diuresis, further decreasing the workload on the failing heart. **Analysis of Incorrect Options:** * **B. Aldosterone antagonist:** This describes **Spironolactone** or Eplerenone, which act on the distal tubule and collecting ducts. * **C. Mercurial derivative:** These are obsolete diuretics (e.g., Mersalyl) rarely used today due to toxicity. * **D. Carbonic anhydrase inhibitor:** This describes **Acetazolamide**, which acts on the proximal convoluted tubule and is primarily used for glaucoma or altitude sickness, not LVF [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Site of Action:** Thick Ascending Limb (TAL) – the "diluting segment." * **Side Effects (The "Hypo"s):** Hypokalemia, Hypomagnesemia, Hypocalcemia (Loop loses Calcium), and Hyperuricemia. * **Ototoxicity:** Furosemide can cause dose-dependent hearing loss, especially when combined with aminoglycosides [2]. * **Drug of Choice:** Furosemide is the DOC for **Acute Pulmonary Edema** and edema associated with CHF, Cirrhosis, and Renal failure [4].
Explanation: ### Explanation **Concept:** The patient is presenting with **severe hypercalcemia** (normal serum calcium is 2.2–2.6 mM; 4.5 mM is a life-threatening emergency). The primary goal in acute hypercalcemia is to enhance urinary calcium excretion. **1. Why Ethacrynic Acid is Correct:** Ethacrynic acid is a **Loop Diuretic**. Loop diuretics (like Furosemide and Ethacrynic acid) inhibit the Na+/K+/2Cl- symporter in the Thick Ascending Limb (TAL) of the Loop of Henle. This action abolishes the positive transepithelial potential, which normally drives the paracellular reabsorption of divalent cations (**Ca²⁺ and Mg²⁺**). Consequently, loop diuretics promote **calciuresis** (calcium excretion). In emergencies, they are administered with saline to prevent volume depletion and further enhance calcium clearance. **2. Why the Other Options are Incorrect:** * **B. Calcitonin:** While calcitonin reduces serum calcium by inhibiting osteoclasts, its effect is slow, relatively weak, and prone to tachyphylaxis. It is an adjunct treatment, but loop diuretics are the classic pharmacological choice for rapid excretion in this context. * **C. Hydrochlorothiazide:** Thiazides are **contraindicated** in hypercalcemia. They increase distal tubular calcium reabsorption, leading to **hypercalcemia**. They are used to treat idiopathic hypercalciuria (kidney stones), not high serum calcium. * **D. Spironolactone:** This is a potassium-sparing diuretic (aldosterone antagonist) acting on the collecting duct. It has no significant effect on calcium excretion. **Clinical Pearls for NEET-PG:** * **Mnemonic:** "Loop Loses" (Loops lose Calcium); "Thiazides Thrive" (Thiazides save Calcium). * **Drug of Choice:** While Ethacrynic acid is a loop diuretic, **Furosemide** is more commonly used in practice. Ethacrynic acid is reserved for patients with **sulfonamide allergies**. * **Acute Management:** The first step in hypercalcemia is always **aggressive IV hydration (Normal Saline)**, followed by loop diuretics. * **Bisphosphonates (e.g., Zoledronate):** These are the gold standard for long-term management of hypercalcemia of malignancy but take 48–72 hours to work.
Explanation: ### Explanation\n\n**1. Why Metolazone is Correct:**\nMost thiazide diuretics lose their efficacy when the Glomerular Filtration Rate (GFR) falls below **30–40 mL/min** [1], [2]. This is because they must be secreted into the tubular lumen to act on the Na⁺-Cl⁻ symporter in the distal convoluted tubule; in renal failure, their delivery to the site of action is significantly impaired. **Metolazone** (and to some extent Indapamide) is a "thiazide-like" diuretic that is uniquely potent. It maintains its diuretic efficacy even in advanced renal insufficiency (GFR as low as 10–20 mL/min) [1].\n\n**2. Why the Other Options are Incorrect:**\n* **Benzthiazide & Chlorothiazide:** These are classical thiazides. They are ineffective in patients with significant renal impairment (GFR < 30 mL/min) because they cannot reach therapeutic concentrations in the tubular fluid [1].\n* **Chlorthalidone:** While it is highly potent and has a long half-life (making it a preferred agent for hypertension), it generally loses its effectiveness as a diuretic when renal function is significantly compromised, unlike Metolazone [1].\n\n**3. High-Yield Clinical Pearls for NEET-PG:**\n* **Synergistic Effect:** Metolazone is frequently added to Loop diuretics (e.g., Furosemide) to overcome **"diuretic resistance"** in patients with refractory edema or congestive heart failure. This is known as **Sequential Nephron Blockade**.\n* **Metabolic Side Effects:** Remember the mnemonic **"Hyper GLUC"** for thiazides: Hyper**G**lycemia, Hyper**L**ipidemia, Hyper**U**ricemia, and Hyper**C**alcemia.\n* **Hypokalemia:** Like loop diuretics, thiazides cause potassium wasting [1].\n* **Indapamide:** Another thiazide-like diuretic often preferred in diabetics as it is considered "metabolically neutral."
Explanation: **Explanation:** **Thiazide diuretics** (e.g., Hydrochlorothiazide, Chlorthalidone) are well-known for causing metabolic side effects, including **impaired glucose tolerance** and hyperglycemia. The underlying mechanism is two-fold: 1. **Hypokalemia-induced inhibition of insulin:** Thiazides cause potassium depletion. Low extracellular potassium levels inhibit the release of insulin from pancreatic beta cells (as insulin secretion is a potassium-dependent process). 2. **Decreased peripheral insulin sensitivity:** Thiazides may also reduce the sensitivity of peripheral tissues to insulin, further elevating blood glucose levels. **Analysis of Incorrect Options:** * **A & D (Spironolactone and Canrenone):** These are **Potassium-sparing diuretics** (Aldosterone antagonists). Unlike Thiazides, they do not cause hypokalemia; in fact, they can cause hyperkalemia. They do not typically interfere with glucose metabolism. * **C (Amiloride):** This is an epithelial sodium channel (ENaC) blocker, also classified as a **Potassium-sparing diuretic**. It is often combined with Thiazides specifically to counteract the potassium loss and mitigate the risk of impaired glucose tolerance. **NEET-PG High-Yield Pearls:** * **Mnemonic for Thiazide Side Effects (Hyper-GLUC):** Hyper**G**lycemia, Hyper**L**ipidemia, Hyper**U**ricemia (can precipitate Gout), and Hyper**C**alcemia. * **Contrast with Loop Diuretics:** While Loop diuretics (Furosemide) can also cause hyperglycemia, the effect is significantly more pronounced and clinically relevant with **Thiazides**. * **Clinical Note:** Thiazides should be used with caution in patients with Diabetes Mellitus or Metabolic Syndrome.
Explanation: ***Furosemide*** - **Loop diuretic** that acts on the **thick ascending limb of Henle** to rapidly promote **natriuresis** and **diuresis**, effectively reducing **preload** in acute pulmonary edema. - First-line treatment for **acute heart failure** with pulmonary edema due to its **rapid onset** and powerful fluid removal capacity. *Thiazide* - **Thiazide diuretics** are less potent and have a **slower onset** of action, making them unsuitable for acute pulmonary edema emergencies. - Primarily used for **chronic hypertension** and **mild heart failure**, not for rapid fluid overload management. *Acetazolamide* - **Carbonic anhydrase inhibitor** with weak diuretic effect, primarily used for **glaucoma**, **altitude sickness**, and **metabolic alkalosis**. - Ineffective for managing **acute fluid overload** due to its limited natriuretic capacity and potential to cause **metabolic acidosis**. *Neomycin* - **Aminoglycoside antibiotic** with no diuretic properties, used to reduce **ammonia-producing bacteria** in hepatic encephalopathy. - Completely unrelated to **fluid management** and would be contraindicated due to potential **nephrotoxicity** in heart failure patients.
Explanation: **Explanation:** **Acetazolamide** is the drug of choice for the prevention and treatment of Acute Mountain Sickness (AMS) [2], [3]. It is a **Carbonic Anhydrase Inhibitor** that acts on the proximal convoluted tubule [4]. **Mechanism in Mountain Sickness:** At high altitudes, low oxygen levels trigger hyperventilation, leading to respiratory alkalosis. Acetazolamide inhibits carbonic anhydrase, causing **bicarbonate diuresis** (bicarbonaturia) [5]. This induces a mild **metabolic acidosis**, which counteracts the respiratory alkalosis. The resulting drop in blood pH stimulates the chemoreceptors, increasing the respiratory drive and improving oxygenation, thereby accelerating acclimatization [2]. It also reduces the formation of cerebrospinal fluid (CSF), helping to decrease intracranial pressure. **Why other options are incorrect:** * **Hydrochlorothiazide (Thiazide):** Primarily used for hypertension and nephrogenic diabetes insipidus; it has no effect on respiratory drive or altitude acclimatization. * **Furosemide (Loop Diuretic):** Used for High-Altitude Pulmonary Edema (HAPE) due to its potent diuretic effect, but it is not used for standard mountain sickness or prophylaxis. * **Spironolactone (K+ Sparing):** An aldosterone antagonist used in cirrhosis or heart failure; it does not influence blood pH or acclimatization. **High-Yield Clinical Pearls for NEET-PG:** * **Site of Action:** Proximal Convoluted Tubule (PCT) [4]. * **Other Uses:** Glaucoma (decreases aqueous humor), Urinary alkalinization (to excrete acidic drugs like aspirin), and Sleep Apnea [1], [2]. * **Key Side Effects:** Hyperchloremic metabolic acidosis, hypokalemia, paresthesia, and sulfa-allergy reactions [2]. * **Contraindication:** Avoid in Hepatic Cirrhosis (can precipitate hepatic encephalopathy by decreasing ammonia excretion) [2], [5].
Carbonic Anhydrase Inhibitors
Practice Questions
Loop Diuretics
Practice Questions
Thiazide and Thiazide-Like Diuretics
Practice Questions
Potassium-Sparing Diuretics
Practice Questions
Carbonic Anhydrase Inhibitors
Practice Questions
Osmotic Diuretics
Practice Questions
Combination Diuretic Therapy
Practice Questions
Diuretics in Heart Failure
Practice Questions
Diuretics in Hypertension
Practice Questions
Diuretics in Renal Disorders
Practice Questions
Adverse Effects and Drug Interactions
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free